Kate Haviland
CIK 1663022 · Chief Executive Officer · last filed 2026-06-10
Kate Haviland is a Chief Executive Officer who has filed 54 SEC Form 4 insider transactions across 4 companies since 2016. The most recent filing, for BCAX, was dated Jun 10, 2026. Across all open-market trades the lifetime net is −$13.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
4
54
-$13.58M
Holdings By Company
Recent Filings
54 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-10 | BCAX | Grant (A) | — | $0 | EDGAR |
| 2026-05-01 | AVLN | Grant (A) | — | $0 | EDGAR |
| 2025-07-21 | Blueprint Medicines Corp (BPMC) Delisted | Mixed | −165,929 | $0 | EDGAR |
| 2025-06-30 | FULC | Grant (A) | — | $0 | EDGAR |
| 2025-06-10 | BCAX | Grant (A) | — | $0 | EDGAR |
| 2025-04-03 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −2,498 | -$216.5K | EDGAR |
| 2025-03-07 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −16,151 | -$1.43M | EDGAR |
| 2025-03-04 | Blueprint Medicines Corp (BPMC) Delisted | Grant (A) | +35,200 | $0 | EDGAR |
| 2025-01-23 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −1,446 | -$159.4K | EDGAR |
| 2024-12-03 | Blueprint Medicines Corp (BPMC) Delisted | Sell (S) | −2,353 | -$227.3K | EDGAR |